 <h1>Cerebyx Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>fosphenytoin</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about fosphenytoin. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Cerebyx.</p><h2>In Summary</h2><p><b>Common side effects of Cerebyx include:</b> pruritus, ataxia, dizziness, drowsiness, nystagmus disorder, burning sensation at injection site, and pain at injection site. <b>Other side effects include:</b> stupor, hypotension, paresthesia, extrapyramidal reaction, headache, nausea, pelvic pain, tinnitus, tongue disease, vasodilation, ecchymoses, and xerostomia.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to fosphenytoin: injection solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Injection route (Solution)</p><p>The rate of IV fosphenytoin sodium administration should not exceed 150 mg phenytoin sodium equivalents (PE) per minute in adults and 2 mg PE/kg/min (or 150 mg PE/min, whichever is slower) in pediatric patients because of the risk of severe hypotension and cardiac arrhythmias. Careful cardiac monitoring is needed during and after administering IV fosphenytoin sodium. Although the risk of cardiovascular toxicity increases with infusion rates above the recommended infusion rate, these events have also been reported at or below the recommended infusion rate. Reduction in rate of administration or discontinuation of dosing may be needed.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, fosphenytoin (the active ingredient contained in Cerebyx) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking fosphenytoin:</p><p>
<i>More common</i>
</p><ul>
<li>Blurred vision</li>
<li>confusion</li>
<li>dizziness, faintness, or lightheadedness when getting up suddenly from a lying or sitting position</li>
<li>feeling of warmth or heat</li>
<li>flushing or redness of the skin, especially on the face and neck</li>
<li>headache</li>
<li>sweating</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>bruising</li>
<li>burning, crawling, itching, numbness, prickling, "pins and needles", or tingling feelings</li>
<li>changes in patterns and rhythms of speech</li>
<li>convulsions</li>
<li>difficulty with speaking</li>
<li>drooling</li>
<li>dry mouth</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>hyperventilation</li>
<li>irritability</li>
<li>itching skin</li>
<li>lack of coordination</li>
<li>large, flat, blue, or purplish patches in the skin</li>
<li>loss of balance control</li>
<li>muscle trembling, jerking, or stiffness</li>
<li>nervousness</li>
<li>problems with movement, walking, or speech</li>
<li>restlessness</li>
<li>shakiness in the legs, arms, hands, or feet</li>
<li>shortness of breath</li>
<li>shuffling walk</li>
<li>slurred speech</li>
<li>stiffness of the limbs</li>
<li>trouble with sleeping</li>
<li>twisting movements of the body</li>
<li>uncontrolled movements, especially of the face, neck, and back</li>
<li>unsteadiness, trembling, or other problems with muscle control or coordination</li>
<li>vomiting</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Abdominal or stomach pain</li>
<li>absence of or decrease in body movement</li>
<li>aggressive or angry</li>
<li>agitation</li>
<li>black, tarry stools</li>
<li>bleeding gums</li>
<li>bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site</li>
<li>blistering, burning, crusting, dryness, or flaking of the skin</li>
<li>blood in the urine or stools</li>
<li>bloody nose</li>
<li>bluish color of the fingernails, lips, skin, palms, or nail beds</li>
<li>body aches or pain</li>
<li>bone pain</li>
<li>burning while urinating</li>
<li>change in consciousness</li>
<li>change in personality</li>
<li>change in the ability to see colors, especially blue or yellow</li>
<li>change in the color of the treated skin</li>
<li>chest pain or discomfort</li>
<li>cloudy urine</li>
<li>cold, clammy skin</li>
<li>congestion</li>
<li>cough or hoarseness</li>
<li>cough producing mucus</li>
<li>coughing or spitting up blood</li>
<li>crying</li>
<li>decrease in frequency of urination</li>
<li>decrease in the amount of urine</li>
<li>deep or fast breathing with dizziness</li>
<li>delusions</li>
<li>dementia</li>
<li>depression</li>
<li>diarrhea</li>
<li>difficulty in passing urine (dribbling)</li>
<li>difficulty with breathing</li>
<li>difficulty with moving</li>
<li>difficulty with swallowing</li>
<li>dilated neck veins</li>
<li>dizziness, fainting, or lightheadedness</li>
<li>drowsiness</li>
<li>dryness or soreness of the throat</li>
<li>dysphoria</li>
<li>euphoria</li>
<li>eye pain</li>
<li>feeling of unreality</li>
<li>feeling that others are watching you or controlling your behavior</li>
<li>feeling that others can hear your thoughts</li>
<li>feeling, seeing, or hearing things that are not there</li>
<li>fever or chills</li>
<li>flushed, dry skin</li>
<li>frequent urination</li>
<li>fruit-like breath odor</li>
<li>general feeling of discomfort or illness</li>
<li>general physical wasting or malnutrition associated with severe illness</li>
<li>greatly increased frequency of urination or amount of urine</li>
<li>headache, severe and throbbing</li>
<li>hives or welts</li>
<li>inability to move the legs or arms</li>
<li>inability to sit still</li>
<li>increase in body movements</li>
<li>increase in heart rate</li>
<li>increased hunger</li>
<li>increased sensitivity of the skin to sunlight</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>increased volume of pale, dilute urine</li>
<li>increased watering of the mouth</li>
<li>irregular breathing</li>
<li>itching, scaling, severe redness, soreness, or swelling of the skin</li>
<li>joint pain</li>
<li>leg cramps</li>
<li>loss of appetite</li>
<li>loss of bladder control</li>
<li>loss of consciousness</li>
<li>loss of memory</li>
<li>loss of strength or energy</li>
<li>lower back or side pain</li>
<li>muscle aches, pains, or stiffness</li>
<li>muscle twitching or jerking</li>
<li>muscular tenderness, wasting, or weakness</li>
<li>nausea or vomiting</li>
<li>need to keep moving</li>
<li>no blood pressure or pulse</li>
<li>not breathing</li>
<li>numbness of the feet, hands, and around the mouth</li>
<li>numbness or tingling in the face, arms, hands, feet, or lips</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>pale skin</li>
<li>paralysis of one side of the body</li>
<li>paranoia</li>
<li>pinpoint red spots on the skin</li>
<li>pounding in the ears</li>
<li>problems with memory</li>
<li>quick to react or overreact emotionally</li>
<li>rapid breathing</li>
<li>rapid heartbeat</li>
<li>rapid weight gain</li>
<li>rapidly changing moods</li>
<li>rash with flat lesions or small raised lesions on the skin</li>
<li>redness of the skin</li>
<li>redness or other discoloration of the skin</li>
<li>rhythmic movement of the muscles</li>
<li>seizures</li>
<li>sense of detachment from self or body</li>
<li>severe constipation</li>
<li>severe headache</li>
<li>severe mood or mental changes</li>
<li>severe pain in the chest</li>
<li>severe sunburn</li>
<li>severe vomiting</li>
<li>shivering</li>
<li>sleeplessness</li>
<li>small lumps under the skin</li>
<li>small red or purple spots on the skin</li>
<li>sneezing</li>
<li>sores, ulcers, or white spots on the lips or in the mouth</li>
<li>spots on your skin resembling a blister or pimple</li>
<li>stiff neck</li>
<li>stopping of heart</li>
<li>stuffy or runny nose</li>
<li>sudden onset of severe breathing difficulty</li>
<li>sudden shortness of breath or troubled breathing</li>
<li>sunken eyes</li>
<li>swelling of the face, fingers, feet, ankles, or lower legs</li>
<li>swelling of the tongue</li>
<li>swollen joints</li>
<li>swollen, painful, or tender lymph glands in the neck, armpit, or groin</li>
<li>tightness of the chest</li>
<li>troubled breathing with exertion</li>
<li>twisting movements of body</li>
<li>unable to sleep</li>
<li>unconsciousness</li>
<li>uncontrolled movements, especially of the face, neck, and back</li>
<li>unexplained weight loss</li>
<li>unusual behavior</li>
<li>unusual bleeding or bruising</li>
<li>unusual weak feeling</li>
<li>voice changes</li>
<li>vomiting of blood or material that looks like coffee grounds</li>
<li>weakness or heaviness of the legs</li>
<li>weight gain</li>
<li>wrinkled skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of fosphenytoin may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Continuing ringing or buzzing or other unexplained noise in the ears</li>
<li>decreased awareness or responsiveness</li>
<li>hearing loss</li>
<li>severe sleepiness</li>
<li>sleepiness or unusual drowsiness</li>
<li>uncontrolled eye movements</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Back pain</li>
<li>change in taste or bad, unusual, or unpleasant (after) taste</li>
<li>change in vision</li>
<li>double vision</li>
<li>feeling of constant movement of self or surroundings</li>
<li>impaired vision</li>
<li>lack or loss of strength</li>
<li>pelvic pain</li>
<li>seeing double</li>
<li>sensation of spinning</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>belching</li>
<li>bigger, dilated, or enlarged pupils (black part of eye)</li>
<li>bloated</li>
<li>burning feeling in the chest or stomach</li>
<li>burning, dry, or itching eyes</li>
<li>change in color vision</li>
<li>difficulty having a bowel movement (stool)</li>
<li>difficulty seeing at night</li>
<li>discharge, excessive tearing</li>
<li>ear pain</li>
<li>excess air or gas in the stomach or intestines</li>
<li>frequent urge to defecate</li>
<li>full feeling</li>
<li>heartburn</li>
<li>increased sense of hearing</li>
<li>increased sensitivity of the eyes to light</li>
<li>indigestion</li>
<li>itching of the vagina or genital area</li>
<li>loss of taste</li>
<li>pain during sexual intercourse</li>
<li>passing gas</li>
<li>redness, pain, swelling of the eye, eyelid, or inner lining of the eyelid</li>
<li>stomach discomfort, upset, or pain</li>
<li>straining while passing stool</li>
<li>tenderness in the stomach area</li>
<li>thick, white vaginal discharge with no odor or with a mild odor</li>
<li>transient, mild, or pleasant aromatic odor</li>
<li>vaginal yeast infection</li>
<li>weight loss</li>
</ul><p>
<!-- end injection solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to fosphenytoin: injectable solution, intravenous solution</i></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (more serious and rare forms have included bullous, exfoliative or purpuric dermatitis, lupus erythematosus, Stevens-Johnson syndrome and toxic epidermal necrolysis), pruritus</p>
<p><b>Common</b> (1% to 10%): Maculopapular rash, urticaria, sweating, skin discoloration, contact dermatitis, pustular rash, skin nodule, ecchymosis</p>
<p><b>Frequency not reported</b>: Hirsutism, hypertrichosis, coarsening of the facial features, enlargement of the lips, Peyronie's disease.  Dupuytren's contracture and drug rash with eosinophilia and systemic symptoms (DRESS), erythema multiforme, SJS/TEN risk in patients of Asian ancestry who have HLA-B 1502<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, vasodilation, tachycardia</p>
<p><b>Uncommon</b> (0.1% to 1%): Shock, cardiac arrest, syncope, cerebral haemorrhage, palpitation, sinus bradycardia, atrial flutter, bundle branch block, cardiomegaly, cerebral infarct, postural hypotension, pulmonary embolus, QT interval prolongation, thrombophlebitis, ventricular extrasystoles, congestive heart failure</p>
<p><b>Frequency not reported</b>: Cardiovascular collapse, severe cardiotoxic reactions with atrial and ventricular conduction depression (including bradycardia and all degrees of heart block), asystole ventricular fibrillation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (13%)</p>
<p><b>Common</b> (1% to 10%): Tongue disorder, dry mouth, vomiting, constipation</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, diarrhea, anorexia, GI hemorrhage, increased salivation, tenesmus, tongue edema, dysphagia, flatulence, gastritis, ileus</p>
<p><b>Frequency not reported</b>: Hypoesthesia of the tongue, gingival hyperplasia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Ecchymosis</p>
<p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia, anemia, leukocytosis, cyanosis, hypochromic anemia, leukopenia, lymphadenopathy, petechia</p>
<p><b>Frequency not reported</b>: Granulocytopenia, agranulocytosis, pancytopenia (with or without bone marrow suppression), aplastic anemia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary retention, oliguria, dysuria, vaginitis, albuminuria, genital edema, polyuria, urethral pain, urinary incontinence, vaginal moniliasis</p>
<p><b>Frequency not reported</b>: Feeling of warmth or tingling in the groin<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Generalized edema, cachexia, diabetes insipidus</p>
<p><b>Frequency not reported</b>: Hyperglycemia, appetite disorder, hypokalemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Liver function tests abnormal</p>
<p><b>Frequency not reported</b>: Toxic hepatitis, hepatocellular damage<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reaction, injection site pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Injection site inflammation, injection site edema, injection site hemorrhage<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity syndrome, periarteritis nodosa, SJS/TEN risk in patients of Asian ancestry who have HLA-B 1502</p>
<p><b>Postmarketing reports</b>: Anaphylactoid reaction, anaphylaxis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Sepsis, flu syndrome, cryptococcosis</p>
<p><b>Frequency not reported</b>: Immunoglobulin abnormalities<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, chills, myasthenia</p>
<p><b>Uncommon</b> (0.1% to 1%): Myopathy, leg cramps, arthralgia, myalgia, muscular weakness, muscle twitching, muscle spasms</p>
<p><b>Frequency not reported</b>: Systemic lupus erythematosus, polyarthritis, Purple Glove Syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Nystagmus (59%), dizziness (31%), somnolence (27%), ataxia (18%)</p>
<p><b>Common</b> (1% to 10%): Headache, stupor, incoordination, paresthesia, extrapyramidal syndrome, tremor, vertigo, brain edema, tinnitus, taste perversion, taste loss,reflexes decreased, reflexes increased, migraine, speech disorder, dysarthria, intracranial hypertension, hyperesthesia, hyporeflexia</p>
<p><b>Uncommon</b> (0.1% to 1%): Twitching, Babinski sign positive, circumoral paresthesia, hemiplegia, hypotonia, convulsion, meningitis, CNS depression, hypokinesia, hyperkinesia, brain edema, paralysis, aphasia, coma, myoclonus, acute brain syndrome, encephalitis, subdural hematoma, encephalopathy, akathisia</p>
<p><b>Frequency not reported</b>: CNS depression, dyskinesia (including chorea), dystonia and asterixis similar to those induced by phenothiazines or other neuroleptic drugs, drowsiness, motor twitching, tonic seizures, sensory peripheral polyneuropathy (in patients receiving long-term therapy)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, deafness, accidental injury, fever, face edema, hyperacusis, parosmia, ear pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Malaise<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Diplopia, amblyopia, blurred vision, visual impairment</p>
<p><b>Uncommon</b> (0.1% to 1%): Photosensitivity reaction, photophobia, eye pain, mydriasis, visual field defect<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Agitation, thinking abnormal, nervousness, depression</p>
<p><b>Uncommon</b> (0.1% to 1%): Confusion, insomnia, depersonalization, psychosis, emotional lability, personality disorder, hostility, amnesia, neurosis, euphoric mood<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Pelvic pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Kidney failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonia</p>
<p><b>Uncommon</b> (0.1% to 1%): Pharyngitis, sinusitis, hyperventilation, rhinitis, apnea, aspiration pneumonia, asthma, dyspnea, atelectasis, cough increased, sputum increased, epistaxis, hypoxia, pneumothorax, hemoptysis, bronchitis</p>
<p><b>Postmarketing reports</b>: Respiratory arrest (sometimes fatal)<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Decreased serum T4 and FT4, increased serum estradiol levels, gynecomastia, alterations in vitamin D metabolism<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Keegan MT,  Bondy LR,  Blackshear JL,  Lanier WL "Hypocalcemia-like electrocardiographic changes after administration of intravenous fosphenytoin." Mayo Clin Proc 77 (2002): 584-6</p></div>
<div class="more-resources" id="moreResources">
<h2>More about Cerebyx (fosphenytoin)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: hydantoin anticonvulsants</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Cerebyx &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Epilepsy</li>
<li>Status Epilepticus</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to fosphenytoin: injectable solution, intravenous solution</i></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Rash (more serious and rare forms have included bullous, exfoliative or purpuric dermatitis, lupus erythematosus, Stevens-Johnson syndrome and toxic epidermal necrolysis), pruritus</p><p><b>Common</b> (1% to 10%): Maculopapular rash, urticaria, sweating, skin discoloration, contact dermatitis, pustular rash, skin nodule, ecchymosis</p><p><b>Frequency not reported</b>: Hirsutism, hypertrichosis, coarsening of the facial features, enlargement of the lips, Peyronie's disease.  Dupuytren's contracture and drug rash with eosinophilia and systemic symptoms (DRESS), erythema multiforme, SJS/TEN risk in patients of Asian ancestry who have HLA-B 1502<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypotension, vasodilation, tachycardia</p><p><b>Uncommon</b> (0.1% to 1%): Shock, cardiac arrest, syncope, cerebral haemorrhage, palpitation, sinus bradycardia, atrial flutter, bundle branch block, cardiomegaly, cerebral infarct, postural hypotension, pulmonary embolus, QT interval prolongation, thrombophlebitis, ventricular extrasystoles, congestive heart failure</p><p><b>Frequency not reported</b>: Cardiovascular collapse, severe cardiotoxic reactions with atrial and ventricular conduction depression (including bradycardia and all degrees of heart block), asystole ventricular fibrillation<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Nausea (13%)</p><p><b>Common</b> (1% to 10%): Tongue disorder, dry mouth, vomiting, constipation</p><p><b>Uncommon</b> (0.1% to 1%): Dyspepsia, diarrhea, anorexia, GI hemorrhage, increased salivation, tenesmus, tongue edema, dysphagia, flatulence, gastritis, ileus</p><p><b>Frequency not reported</b>: Hypoesthesia of the tongue, gingival hyperplasia<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Ecchymosis</p><p><b>Uncommon</b> (0.1% to 1%): Thrombocytopenia, anemia, leukocytosis, cyanosis, hypochromic anemia, leukopenia, lymphadenopathy, petechia</p><p><b>Frequency not reported</b>: Granulocytopenia, agranulocytosis, pancytopenia (with or without bone marrow suppression), aplastic anemia<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Uncommon</b> (0.1% to 1%): Urinary retention, oliguria, dysuria, vaginitis, albuminuria, genital edema, polyuria, urethral pain, urinary incontinence, vaginal moniliasis</p><p><b>Frequency not reported</b>: Feeling of warmth or tingling in the groin<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Generalized edema, cachexia, diabetes insipidus</p><p><b>Frequency not reported</b>: Hyperglycemia, appetite disorder, hypokalemia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Uncommon</b> (0.1% to 1%): Liver function tests abnormal</p><p><b>Frequency not reported</b>: Toxic hepatitis, hepatocellular damage<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Injection site reaction, injection site pain</p><p><b>Uncommon</b> (0.1% to 1%): Injection site inflammation, injection site edema, injection site hemorrhage<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Frequency not reported</b>: Hypersensitivity syndrome, periarteritis nodosa, SJS/TEN risk in patients of Asian ancestry who have HLA-B 1502</p><p><b>Postmarketing reports</b>: Anaphylactoid reaction, anaphylaxis<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Uncommon</b> (0.1% to 1%): Sepsis, flu syndrome, cryptococcosis</p><p><b>Frequency not reported</b>: Immunoglobulin abnormalities<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Back pain, chills, myasthenia</p><p><b>Uncommon</b> (0.1% to 1%): Myopathy, leg cramps, arthralgia, myalgia, muscular weakness, muscle twitching, muscle spasms</p><p><b>Frequency not reported</b>: Systemic lupus erythematosus, polyarthritis, Purple Glove Syndrome<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Nystagmus (59%), dizziness (31%), somnolence (27%), ataxia (18%)</p><p><b>Common</b> (1% to 10%): Headache, stupor, incoordination, paresthesia, extrapyramidal syndrome, tremor, vertigo, brain edema, tinnitus, taste perversion, taste loss,reflexes decreased, reflexes increased, migraine, speech disorder, dysarthria, intracranial hypertension, hyperesthesia, hyporeflexia</p><p><b>Uncommon</b> (0.1% to 1%): Twitching, Babinski sign positive, circumoral paresthesia, hemiplegia, hypotonia, convulsion, meningitis, CNS depression, hypokinesia, hyperkinesia, brain edema, paralysis, aphasia, coma, myoclonus, acute brain syndrome, encephalitis, subdural hematoma, encephalopathy, akathisia</p><p><b>Frequency not reported</b>: CNS depression, dyskinesia (including chorea), dystonia and asterixis similar to those induced by phenothiazines or other neuroleptic drugs, drowsiness, motor twitching, tonic seizures, sensory peripheral polyneuropathy (in patients receiving long-term therapy)<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, deafness, accidental injury, fever, face edema, hyperacusis, parosmia, ear pain</p><p><b>Uncommon</b> (0.1% to 1%): Malaise<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Diplopia, amblyopia, blurred vision, visual impairment</p><p><b>Uncommon</b> (0.1% to 1%): Photosensitivity reaction, photophobia, eye pain, mydriasis, visual field defect<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Agitation, thinking abnormal, nervousness, depression</p><p><b>Uncommon</b> (0.1% to 1%): Confusion, insomnia, depersonalization, psychosis, emotional lability, personality disorder, hostility, amnesia, neurosis, euphoric mood<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): Pelvic pain</p><p><b>Uncommon</b> (0.1% to 1%): Kidney failure<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Pneumonia</p><p><b>Uncommon</b> (0.1% to 1%): Pharyngitis, sinusitis, hyperventilation, rhinitis, apnea, aspiration pneumonia, asthma, dyspnea, atelectasis, cough increased, sputum increased, epistaxis, hypoxia, pneumothorax, hemoptysis, bronchitis</p><p><b>Postmarketing reports</b>: Respiratory arrest (sometimes fatal)<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Frequency not reported</b>: Decreased serum T4 and FT4, increased serum estradiol levels, gynecomastia, alterations in vitamin D metabolism<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Keegan MT,  Bondy LR,  Blackshear JL,  Lanier WL "Hypocalcemia-like electrocardiographic changes after administration of intravenous fosphenytoin." Mayo Clin Proc 77 (2002): 584-6</p><h2>More about Cerebyx (fosphenytoin)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: hydantoin anticonvulsants</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Cerebyx &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Epilepsy</li>
<li>Status Epilepticus</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>